UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045092
Receipt number R000051510
Scientific Title Clinical evaluation of high resolution retinal ganglion cell imaging
Date of disclosure of the study information 2021/08/08
Last modified on 2021/09/10 19:41:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical evaluation of high resolution retinal ganglion cell imaging

Acronym

Clinical evaluation of high resolution retinal ganglion cell imaging

Scientific Title

Clinical evaluation of high resolution retinal ganglion cell imaging

Scientific Title:Acronym

Clinical evaluation of high resolution retinal ganglion cell imaging

Region

Japan


Condition

Condition

glaucoma, retinal diseases, optic nerve associated diseases

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

A clinical research prototype of the Adaptive Optics-Scanning Laser Ophthalmoscope (AO-SLO), spectral-domain optical coherence tomography (SS-OCT), was used to image human eyes. The purpose of this study is to compare glaucomatous eyes with normal eyes and to evaluate the clinical usefulness of the acquired high-resolution fundus images of intraretinal cells, including retinal ganglion cells, and vascular indices.

Basic objectives2

Others

Basic objectives -Others

To search and evaluate novel index.

Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Each of the following items will be evaluated, as well as the correlation between each item.
1) Items to examine the difference between healthy and pathological eyes
Various parameters of cells in the retina, including retinal ganglion cells (number of cells at each position in the retina, cell density, cell arrangement, etc.)
2) Items to be examined for differences between the test device and other ophthalmic devices (OCT, etc.) Findings based on images and measurement data
3) Items to examine the differences in physical findings

Translated with www.DeepL.com/Translator (free version)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Visual acuity test, intraocular pressure test, visual field test, fundus photography, optical coherence tomography, adaptive optics optical coherence tomography system, etc.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Glaucoma group (Glaucomatous eyes)
1) Able to undergo regular ophthalmologic examinations at the Department of Ophthalmology, Kyoto University Hospital by ophthalmologist 2) Aged 40 years or older at the time of case registration 3) Any gender 4) Having eyes diagnosed as primary open-angle glaucoma (broad sense) by ophthalmologist 5) Without a history of severe or uncontrolled systemic disease 6) Written consent for participation in the study has been obtained from the subject himself/herself. Control group (healthy eyes) 1) Able to undergo multiple ophthalmologic examinations at the Department of Ophthalmology, Kyoto University Hospital. 2) Aged 40 years or older at the time of case enrollment. 3) Any gender. 4) Without a history of severe or uncontrolled systemic disease, and without retinal disease (including suspected glaucoma and anterior segment glaucoma) in at least one eye. 5) Written consent for participation in the study has been obtained from the subject.

Key exclusion criteria

Glaucoma group (glaucomatous eyes) 1) History of retinal disease (macular edema, retinal detachment, diabetic retinopathy, pathological myopia, etc.) or optic neuropathy other than glaucoma 2) Severe glaucoma (MD below -12 dB, etc.) 3) History of adverse reaction (hypersensitivity, increased intraocular pressure, etc.) to mydriatic agent 4) Narrow angle is observed in a slit-lamp examination, and mydriasis is considered to have a high risk of inducing an acute glaucoma attack. 5) Inability to perform appropriate fundus observation using AO-OCT due to lens opacity caused by cataract. 6) Lack of corrected visual acuity to perform visual field testing appropriately. 7) History of corneal refractive surgery or severe ocular trauma. 8) Corneal or conjunctival abnormality that prevents appropriate measurement of intraocular pressure using a tonometer 9) Other cases that the principal investigator or the physician in charge deems inappropriate for the safe conduct of this study Control group (healthy eyes) In addition to 3) to 9) of "Glaucoma eyes," the following will be included. 1) Suspected glaucoma, anterior segment glaucoma, retinal disease (macular edema, retinal detachment, diabetic retinopathy, pathological myopia, etc.), or a history of optic neuropathy other than glaucoma

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Akitaka
Middle name
Last name Tujikawa

Organization

Kyoto University Graduate School of Medicine

Division name

Ophthalmology & Visual Sciences

Zip code

606-8507

Address

54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, JAPAN

TEL

075-751-3250

Email

tujikawa@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name Shogo
Middle name
Last name Numa

Organization

Kyoto University Graduate School of Medicine

Division name

Ophthalmology & Visual Sciences

Zip code

606-8507

Address

54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, JAPAN

TEL

075-751-3250

Homepage URL


Email

numa1988@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto University Graduate School of Medicine,Department of Ophthalmology & Visual Sciences

Institute

Department

Personal name



Funding Source

Organization

Santen

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

CANON INC.,Santen

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto University Graduate School and Faculty of Medicine, Ethics Committee

Address

Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, JAPAN

Tel

075-753-4680

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 08 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 08 Month 31 Day

Date of IRB


Anticipated trial start date

2021 Year 11 Month 01 Day

Last follow-up date

2023 Year 10 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 08 Month 07 Day

Last modified on

2021 Year 09 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051510


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name